Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033.
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.
Virtual rehabilitation for multiple sclerosis using a kinect-based system: randomized controlled trial.
Early CNS neurodegeneration in radiologically isolated syndrome.
Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: Sexual dimorphism and diergism at the spinal cord level.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosis.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication.
Synthesis of genistein coupled with sugar derivatives and their inhibitory effect on nitric oxide production in macrophages.
Quality of life outcomes following surgery for patients with coexistent cervical stenosis and multiple sclerosis.
Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients.
Endothelial microparticles interact with and support the proliferation of T cells.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
Severe relapses under fingolimod treatment prescribed after natalizumab.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Alemtuzumab for multiple sclerosis.
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident optic neuritis.
Longitudinal follow-up of vision in a neuromyelitis optica cohort.
Reduced habituation of the retinal ganglion cell response to sustained pattern stimulation in multiple sclerosis patients.
A Qualitative Study Exploring the Usability of Nintendo Wii Fit among Persons with Multiple Sclerosis.
Pages
« first
‹ previous
…
354
355
356
357
358
359
360
361
362
…
next ›
last »